Fortekor Plus 1.25 mg pimobendan/2.5 mg benazepril HCl Tablets for Dogs

Country: Նոր Զելանդիա

language: անգլերեն

source: Ministry for Primary Industries

active_ingredient:

pimobendan; benazepril hydrochloride

MAH:

Elanco Australasia Pty Ltd

INN:

benazepril hydrochloride, pimobendan

composition:

pimobendan 3.76 g/kg; benazepril hydrochloride 150.38 g/kg

therapeutic_area:

Cardiovascular agent

authorization_status:

ACVM Registered

authorization_date:

2016-02-23

SPC

COMPANY CONFIDENTIAL
PRODUCT NAME: Fortekor Plus 1.25 mg/2.5 mg, Fortekor Plus 5 mg/10 mg
REVISION DATE: 07 Jun 2019
PAGE: 1 of 7
PACK SIZES: Not sold
TYPE OF LABEL: blister, leaflet and carton
PREPARED BY: Yan Er
COUNTRY: NZ
REASON: MAT
Text above this line is not included in the actual label.
GENERIC PRODUCT NAME:
VERSION:
REVISION DATE
ACVM CODE
Fortekor plus 1.25/2.5 & 5/10 mg
FINAL
07 Jun 2019
A011169 & A011170
COPYRIGHT © 2019 ELANCO OR ITS AFFILIATES
_BLISTER _
FOR ANIMAL TREATMENT ONLY
FORTEKOR PLUS
1.25 MG/2.5 MG TABLETS FOR DOGS
PIMOBENDAN/BENAZEPRIL HYDROCHLORIDE
(FORTEKOR PLUS
5 MG/10 MG TABLETS FOR DOGS
PIMOBENDAN/BENAZEPRIL HYDROCHLORIDE)
Elanco Logo
Lot:
Exp:
COMPANY CONFIDENTIAL
PRODUCT NAME: Fortekor Plus 1.25 mg/2.5 mg, Fortekor Plus 5 mg/10 mg
REVISION DATE: 07 Jun 2019
PAGE: 2 of 7
PACK SIZES: Not sold
TYPE OF LABEL: blister, leaflet and carton
PREPARED BY: Yan Er
COUNTRY: NZ
REASON: MAT
Text above this line is not included in the actual label.
GENERIC PRODUCT NAME:
VERSION:
REVISION DATE
ACVM CODE
Fortekor plus 1.25/2.5 & 5/10 mg
FINAL
07 Jun 2019
A011169 & A011170
COPYRIGHT © 2019 ELANCO OR ITS AFFILIATES
_CARTON – FRONT AND REAR PANEL _
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
FORTEKOR PLUS 1.25 MG PIMOBENDAN/2.5 MG BENAZEPRIL HCL TABLETS FOR
DOGS
(FORTEKOR PLUS 5 MG PIMOBENDAN/10 MG BENAZEPRIL HCL TABLETS FOR DOGS)
ACTIVE CONSTITUENTS:
EACH TABLET CONTAINS
1.25 MG PIMOBENDAN (5 MG PIMOBENDAN)
2.5 MG BENAZEPRIL HYDROCHLORIDE (10 MG BENAZEPRIL HYDROCHLORIDE)
For the treatment of congestive heart failure due to atrioventricular
valve
insufficiency or dilated cardiomyopathy in dogs.
30 tablets (60 tablets)
(5 mg/10 mg 30 tablets; 60 tablets)
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE
DO NOT USE IN CASES OF HYPOTENSION, HYPOVOLEMIA OR ACUTE RENAL
FAILURE.
DO NOT USE IN DOGS WITH HYPERTROPHIC CARDIOMYOPATHY OR IN CASES OF
CARDIAC
OUTPUT FAILURE DUE TO AORTIC OR PULMONARY STENOSIS.
DOSAGE AND ADMINISTRATION
Daily oral admi